Albumin againBMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7194.1352-b (Published 15 May 1999) Cite this as: BMJ 1999;318:1352
View Full Text
- Peter Horsey, Honorary consultant anaesthetist (firstname.lastname@example.org)
- Shackleton Department of Anaesthetics, Southampton General Hospital, Southampton SO16 6YD
EDITOR—There are only two explanations for the conclusions of the Cochrane review of human albumin administration in critically ill patients—either that albumin was given in excessive amounts or that the commercial processing it undergoes makes it toxic. Several correspondents writing about the review call for expert appraisal of the evidence on which it was based.1
As a start I suggest that attention should be directed …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.